Massive HCM database aims to unlock better heart care
NCT ID NCT07638033
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will collect health information from 3000 people with hypertrophic cardiomyopathy (HCM) across multiple hospitals in China. The goal is to build a comprehensive database to understand how the disease is currently diagnosed and treated, and to identify factors that affect patient outcomes. No new treatments are being tested; instead, researchers will observe routine care to improve future management of HCM.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY (HCM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
the First Affiliated Hospital of the Air Force Medical University
Xi'an, China/Shaan XI Province, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scan AI could predict sudden cardiac death risk in common heart condition
- Experimental pill aims to ease thick heart muscle symptoms
- Heart drug swap tested for safer symptom control
- Real-World HCM drug use under the microscope
- Heart drug mavacamten shows promise in Real-World study
- Can a new heart drug improve blood flow in thick heart muscle?